cisatracurium (Nimbex)

From Aaushi
Jump to navigation Jump to search

Introduction

Tradename: Nimbex. (cisatracurium besylate)

Indications

Contraindications

Caution:

pregnancy category = b

safety in lactation = ?

Dosage

Injection: 2 mg/mL (5 & 10 mL); 10 mg/mL (20 mL).

Pharmacokinetics

  • Duration: 30-60 minutes.

elimination via plasma

Adverse effects

Overdose:

Drug interactions

Mechanism of action

More general terms

Additional terms

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  3. Department of Veterans Affairs, VA National Formulary

Database